Evidence map›Paper›PMID 38910497›Full record

ArticleJournal of Zhejiang University. Science. B2024

Clinical characteristics and outcomes of hospitalized kidney transplant recipients with COVID-19 infection in China during the Omicron wave: a single-center cohort study.

Duo Lv, Xishao Xie, Qinyun Yang, Zhimin Chen, Guangjun Liu, Wenhan Peng, Rending Wang, Hongfeng Huang, Jianghua Chen, Jianyong Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Duo LvDepartment of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Xishao XieKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Qinyun YangInformation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Zhimin ChenKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Guangjun LiuKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Wenhan PengKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Rending WangKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Hongfeng HuangKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Jianghua ChenKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Jianyong WuKidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. wujianyong1964@zju.edu.cn.

Funding

the National Natural Science Foundation of China 2022YFC82200842the Zhejiang Provincial Natural Science Foundation of China LQ22H050004
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCOVID-19Kidney TransplantationSARS-CoV-2AdultAgedAntibodies, Monoclonal, HumanizedAzetidinesChinaCOVID-19 Drug TreatmentFemaleHospitalizationHumansMaleMiddle AgedPurinesAntibodies, Monoclonal, HumanizedAntiviral AgentsAzetidinesbaricitinibPurinesPyrazolesSulfonamidestocilizumabCoronavirus disease 2019 (COVID-19)HospitalizationKidney transplantMortality

Identifiers

PMID38910497
PMCPMC11199089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.